Acquisitions (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Apr. 30, 2025 |
Feb. 28, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
|
| Asset Acquisition [Line Items] | ||||||||
| Payments to acquire businesses | $ 65,302 | $ 0 | ||||||
| Goodwill | $ 283,190 | 283,190 | $ 283,190 | |||||
| Impairment | $ 0 | $ (790,000) | $ (59,138) | $ (790,000) | ||||
| UpLift Health Technologies, Inc | ||||||||
| Asset Acquisition [Line Items] | ||||||||
| Consideration transferred | $ 29,600 | |||||||
| Contingent consideration | $ 15,000 | |||||||
| Catapult Health | ||||||||
| Asset Acquisition [Line Items] | ||||||||
| Payments to acquire businesses | $ 65,300 | |||||||
| Cash acquired from acquisition | 100 | |||||||
| Contingent earnout consideration | 3,800 | |||||||
| Intangible assets | 12,700 | |||||||
| Goodwill | $ 59,100 | |||||||
| Deductible percent | 73.00% | |||||||
| Impairment | $ (59,100) | |||||||
| Teladoc Health | ||||||||
| Asset Acquisition [Line Items] | ||||||||
| Business combination, cash transaction amount | $ 27,000 | |||||||
| X | ||||||||||
- Definition Business Acquisition, Goodwill, Expected Tax Deductible Amount, Percent No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of contingent consideration recognized as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|